眾愛可維2019冠狀病毒病疫苗

zh

WikiRank.net
ver. 1.6

眾愛可維2019冠狀病毒病疫苗

Quality:

BBIBP-CorV - Chinese inactivated virus candidate vaccine against COVID-19. Article "眾愛可維2019冠狀病毒病疫苗" in Chinese Wikipedia has 48.1 points for quality (as of July 1, 2025). The article contains 25 references and 11 sections. The article also contains quality flaw template, which reduce quality score.

This article has the best quality in English Wikipedia. Also, this article is the most popular in that language version.

Since the creation of article "眾愛可維2019冠狀病毒病疫苗", its content was written by 33 registered users of Chinese Wikipedia and edited by 334 registered Wikipedia users in all languages.

The article is cited 871 times in Chinese Wikipedia (9527th place) and cited 4301 times in all languages.

The highest Authors Interest rank from 2001:

  • Local (Chinese): #203 in May 2021
  • Global: #1865 in May 2021

The highest popularity rank from 2008:

  • Local (Chinese): #2342 in June 2021
  • Global: #1268 in September 2021

There are 25 language versions for this article in the WikiRank database (of the considered 55 Wikipedia language editions).

The quality and popularity assessment was based on Wikipédia dumps from July 1, 2025 (including revision history and pageviews for previous years).

The table below shows the language versions of the article with the highest quality.

Languages with the highest quality

#LanguageQuality gradeQuality score
1English (en)
Sinopharm BIBP COVID-19 vaccine
85.7143
2Thai (th)
วัคซีนโควิด-19 BBIBP-CorV ของซิโนฟาร์ม
79.2381
3Ukrainian (uk)
BBIBP-CorV
66.2809
4Hungarian (hu)
Sinopharm-Covid19-vakcina
65.5317
5Persian (fa)
واکسن کووید-۱۹ سینوفارم
65.153
6Spanish (es)
Vacuna de Sinopharm contra la COVID-19
56.0865
7Esperanto (eo)
Vakcino de la kronvirusa malsano de 2019 de Sinopharm BIBP
55.3648
8Japanese (ja)
シノファームCOVID-19ワクチン
53.2542
9Chinese (zh)
眾愛可維2019冠狀病毒病疫苗
48.1077
10Catalan (ca)
BBIBP-CorV
48.0175
More...

The following table shows the most popular language versions of the article.

Most popular in all the time

The most popular language versions of the article "眾愛可維2019冠狀病毒病疫苗" in all the time
#LanguagePopularity awardRelative popularity
1English (en)
Sinopharm BIBP COVID-19 vaccine
1 104 496
2Persian (fa)
واکسن کووید-۱۹ سینوفارم
636 215
3Spanish (es)
Vacuna de Sinopharm contra la COVID-19
187 628
4Chinese (zh)
眾愛可維2019冠狀病毒病疫苗
147 526
5Russian (ru)
BBIBP-CorV
58 859
6French (fr)
BBIBP-CorV
46 803
7Arabic (ar)
BBIBP-CorV
37 300
8Thai (th)
วัคซีนโควิด-19 BBIBP-CorV ของซิโนฟาร์ม
31 396
9Japanese (ja)
シノファームCOVID-19ワクチン
30 672
10German (de)
BBIBP-CorV
27 332
More...

The following table shows the language versions of the article with the highest popularity in the last month.

Most popular in June 2025

The most popular language versions of the article "眾愛可維2019冠狀病毒病疫苗" in June 2025
#LanguagePopularity awardRelative popularity
1English (en)
Sinopharm BIBP COVID-19 vaccine
1 463
2Persian (fa)
واکسن کووید-۱۹ سینوفارم
375
3Spanish (es)
Vacuna de Sinopharm contra la COVID-19
342
4Chinese (zh)
眾愛可維2019冠狀病毒病疫苗
315
5Hungarian (hu)
Sinopharm-Covid19-vakcina
168
6Japanese (ja)
シノファームCOVID-19ワクチン
85
7Catalan (ca)
BBIBP-CorV
67
8Russian (ru)
BBIBP-CorV
60
9Norwegian (no)
Sinopharms COVID-19-vaksine (BBIBP-CorV)
40
10Italian (it)
BBIBP-CorV
36
More...

The following table shows the language versions of the article with the highest Authors’ Interest.

The highest AI

Language versions of the article "眾愛可維2019冠狀病毒病疫苗" with the highest Authors Interest (number of authors). Only registered Wikipedia users were taken into account.
#LanguageAI awardRelative AI
1English (en)
Sinopharm BIBP COVID-19 vaccine
103
2Chinese (zh)
眾愛可維2019冠狀病毒病疫苗
33
3Persian (fa)
واکسن کووید-۱۹ سینوفارم
29
4French (fr)
BBIBP-CorV
15
5German (de)
BBIBP-CorV
14
6Spanish (es)
Vacuna de Sinopharm contra la COVID-19
14
7Hungarian (hu)
Sinopharm-Covid19-vakcina
14
8Japanese (ja)
シノファームCOVID-19ワクチン
13
9Russian (ru)
BBIBP-CorV
13
10Vietnamese (vi)
BBIBP-CorV
9
More...

The following table shows the language versions of the article with the highest Authors’ Interest in the last month.

The highest AI in June 2025

Language versions of the article "眾愛可維2019冠狀病毒病疫苗" with the highest AI in June 2025
#LanguageAI awardRelative AI
1English (en)
Sinopharm BIBP COVID-19 vaccine
1
2Korean (ko)
시노팜 BBIBP-CorV 코로나19 백신
1
3Arabic (ar)
BBIBP-CorV
0
4Catalan (ca)
BBIBP-CorV
0
5Czech (cs)
Vakcína Sinopharm BIBP proti covidu-19
0
6German (de)
BBIBP-CorV
0
7Esperanto (eo)
Vakcino de la kronvirusa malsano de 2019 de Sinopharm BIBP
0
8Spanish (es)
Vacuna de Sinopharm contra la COVID-19
0
9Persian (fa)
واکسن کووید-۱۹ سینوفارم
0
10French (fr)
BBIBP-CorV
0
More...

The following table shows the language versions of the article with the highest number of citations.

The highest CI

Language versions of the article "眾愛可維2019冠狀病毒病疫苗" with the highest Citation Index (CI)
#LanguageCI awardRelative CI
1English (en)
Sinopharm BIBP COVID-19 vaccine
1 552
2Chinese (zh)
眾愛可維2019冠狀病毒病疫苗
871
3Korean (ko)
시노팜 BBIBP-CorV 코로나19 백신
338
4Vietnamese (vi)
BBIBP-CorV
317
5Japanese (ja)
シノファームCOVID-19ワクチン
306
6Italian (it)
BBIBP-CorV
299
7Catalan (ca)
BBIBP-CorV
104
8Ukrainian (uk)
BBIBP-CorV
89
9French (fr)
BBIBP-CorV
64
10Hungarian (hu)
Sinopharm-Covid19-vakcina
58
More...

Scores

Estimated value for Wikipedia:
Chinese:
Global:
Popularity in June 2025:
Chinese:
Global:
Popularity in all years:
Chinese:
Global:
Authors in June 2025:
Chinese:
Global:
Registered authors in all years:
Chinese:
Global:
Citations:
Chinese:
Global:

Quality measures

Interwikis

#LanguageValue
arArabic
BBIBP-CorV
caCatalan
BBIBP-CorV
csCzech
Vakcína Sinopharm BIBP proti covidu-19
deGerman
BBIBP-CorV
enEnglish
Sinopharm BIBP COVID-19 vaccine
eoEsperanto
Vakcino de la kronvirusa malsano de 2019 de Sinopharm BIBP
esSpanish
Vacuna de Sinopharm contra la COVID-19
faPersian
واکسن کووید-۱۹ سینوفارم
frFrench
BBIBP-CorV
huHungarian
Sinopharm-Covid19-vakcina
idIndonesian
BBIBP-CorV
itItalian
BBIBP-CorV
jaJapanese
シノファームCOVID-19ワクチン
koKorean
시노팜 BBIBP-CorV 코로나19 백신
msMalay
BBIBP-CorV
nlDutch
BBIBP-CorV
noNorwegian
Sinopharms COVID-19-vaksine (BBIBP-CorV)
ptPortuguese
BBIBP-CorV
ruRussian
BBIBP-CorV
svSwedish
BBIBP-CorV
thThai
วัคซีนโควิด-19 BBIBP-CorV ของซิโนฟาร์ม
ukUkrainian
BBIBP-CorV
uzUzbek
BBIBP-CorV
viVietnamese
BBIBP-CorV
zhChinese
眾愛可維2019冠狀病毒病疫苗

Popularity rank trends

Best Rank Chinese:
#2342
06.2021
Global:
#1268
09.2021

AI rank trends

Best Rank Chinese:
#203
05.2021
Global:
#1865
05.2021

Local popularity rank history

Global popularity rank history

Local AI rank history

Global AI rank history

Languages comparison

Important global interconnections (July 2024 – June 2025)

Wikipedia readers most often find their way to information on BBIBP-CorV from Wikipedia articles about COVID-19 vaccine, List of COVID-19 vaccine authorizations, Gam-COVID-Vac, COVID-19 vaccination in mainland China‎ and Sinopharm. Whereas reading the article about BBIBP-CorV people most often go to Wikipedia articles on Sinopharm, Inactivated vaccine, CoronaVac, COVID-19 vaccine and Pfizer–BioNTech COVID-19 vaccine.

Cumulative results of quality and popularity of the Wikipedia article

List of Wikipedia articles in different languages (starting with the most popular):

News from 12 August 2025

On 12 August 2025 in multilingual Wikipedia, Internet users most often read articles on the following topics: Cristiano Ronaldo, Wednesday, Georgina Rodríguez, ChatGPT, Weapons, Jenna Ortega, deaths in 2025, Taylor Swift, Miguel Uribe Turbay, 2025–26 UEFA Champions League.

In Chinese Wikipedia the most popular articles on that day were: 朱由𣜬, 林岱樺, 林逸欣, 江油未成年人欺凌事件, 鬼滅之刃, 黃士修, 鬼滅之刃角色列表, 锦月如歌, 2025年亞洲盃籃球賽, 鬼滅之刃劇場版 無限城篇.

About WikiRank

The WikiRank project is intended for automatic relative evaluation of the articles in the various language versions of Wikipedia. At the moment the service allows to compare over 44 million Wikipedia articles in 55 languages. Quality scores of articles are based on Wikipedia dumps from July, 2025. When calculating current popularity and AI of articles data from June 2025 was taken into account. For historical values of popularity and AI WikiRank used data from 2001 to 2025... More information